| Withdrawn | To Assess the Efficacy and Safety of PT010 Compared to PT009 in Subjects With Moderate to Very Severe Chronic Chronic Obstructive Pulmonary Disease | Phase 3 | 2018-04-16 |
| Completed | Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma Asthma | Phase 2 / Phase 3 | 2017-12-13 |
| Completed | A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relati Chronic Obstructive Pulmonary Disease | Phase 1 | 2017-10-17 |
| Completed | A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose Chronic Obstructive Pulmonary Disease | Phase 1 | 2017-08-11 |
| Completed | Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects Chronic Obstructive Pulmonary Disease | Phase 1 | 2017-04-17 |
| Completed | A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moder COPD, Chronic Obstructive Pulmonary Disease | Phase 3 | 2016-12-29 |
| Terminated | Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Se COPD | Phase 3 | 2016-12-09 |
| Completed | Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared Wit COPD | Phase 3 | 2016-08-09 |
| Completed | Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Func Chronic Obstructive Pulmonary Disorder | Phase 3 | 2016-05-31 |
| Completed | A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Peri Chronic Obstructive Pulmonary Disorder | Phase 3 | 2016-04-29 |
| Completed | A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance i COPD | Phase 3 | 2015-12-23 |
| Completed | A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy COPD | Phase 3 | 2015-08-10 |
| Completed | Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe COPD | Phase 3 | 2015-08-10 |
| Completed | Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very COPD | Phase 3 | 2015-06-30 |
| Completed | Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects Asthma | Phase 2 | 2015-05-27 |
| Completed | Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Mod COPD | Phase 3 | 2015-05-01 |
| Completed | Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe CO Chronic Obstructive Pulmonary Disease | Phase 3 | 2015-03-30 |
| Completed | 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI COPD | Phase 3 | 2015-02-01 |
| Completed | 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spi COPD | Phase 3 | 2015-02-01 |
| Completed | Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe C Chronic Obstructive Pulmonary Disease | Phase 2 | 2015-01-28 |
| Completed | Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Mo COPD | Phase 3 | 2014-11-01 |
| Completed | Randomized, Crossover Safety and Pharmacokinetics Study of PT010 COPD | Phase 1 | 2014-08-01 |
| Completed | Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive P Chronic Obstructive Pulmonary Disease | Phase 2 | 2014-08-01 |
| Completed | PK Study of PT003 and PT001 in Japanese Healthy Subjects COPD | Phase 1 | 2014-07-01 |
| Completed | Pharmacokinetics and Safety Study of PT010 in Healthy Subjects COPD | Phase 1 | 2014-06-01 |
| Completed | Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPD Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2014-05-01 |
| Completed | Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persiste Asthma | Phase 2 | 2014-04-01 |
| Completed | Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarat Healthy Volunteers | Phase 1 | 2013-11-01 |
| Completed | Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Ve Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2013-11-01 |
| Completed | Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to V Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2013-07-01 |
| Completed | Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pu Chronic Obstructive Pulmonary Disease | Phase 3 | 2013-05-01 |
| Completed | Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate t Chronic Obstructive Pulmonary Disease | Phase 2 | 2012-04-01 |
| Completed | PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD Chronic Obstructive Pulmonary Disease | Phase 2 | 2012-03-01 |
| Completed | PT003 MDI Dose Confirmation Study Chronic Obstructive Pulmonary Disease | Phase 2 | 2011-06-01 |
| Completed | PT003 MDI Cardiovascular Safety Study Chronic Obstructive Pulmonary Disease | Phase 2 | 2011-05-01 |
| Completed | PT005 MDI Dose Ranging Versus Foradil Aerolizer Study Chronic Obstructive Pulmonary Disease | Phase 2 | 2011-05-01 |
| Completed | PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease | Phase 2 | 2011-05-01 |
| Withdrawn | Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructiv COPD | Phase 2 | 2010-07-01 |
| Completed | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosin Chronic Obstructive Pulmonary Disease | Phase 2 | 2010-03-01 |
| Completed | Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects Healthy Volunteers | Phase 1 | 2009-05-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Dise Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | 2009-03-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Dise Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | 2008-11-01 |